News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
545,031 Results
Type
Article (36743)
Company Profile (231)
Press Release (508057)
Section
Business (163676)
Career Advice (1192)
Deals (28784)
Drug Delivery (66)
Drug Development (60938)
Employer Resources (107)
FDA (14015)
Job Trends (11736)
News (271344)
Policy (23610)
Tag
Academia (2197)
Alliances (44664)
Alzheimer's disease (944)
Approvals (13951)
Artificial intelligence (129)
Bankruptcy (214)
Best Places to Work (9535)
Biotechnology (179)
Breast cancer (84)
Cancer (783)
Career advice (1005)
Cell therapy (196)
Clinical research (47463)
Collaboration (312)
Compensation (83)
COVID-19 (2002)
Cystic fibrosis (75)
Data (752)
Diabetes (94)
Diagnostics (5839)
Earnings (61817)
Employer resources (97)
Events (76910)
Executive appointments (207)
FDA (14384)
Funding (264)
Gene therapy (171)
GLP-1 (391)
Government (2739)
Healthcare (15164)
Infectious disease (2064)
Inflammatory bowel disease (84)
Interviews (188)
IPO (13026)
Job creations (2522)
Job search strategy (872)
Layoffs (312)
Legal (5571)
Lung cancer (136)
Manufacturing (128)
Medical device (12400)
Medtech (12405)
Mergers & acquisitions (15844)
Metabolic disorders (267)
Neuroscience (1142)
NextGen Class of 2024 (5051)
Non-profit (3113)
Northern California (981)
Obesity (159)
Opinion (172)
Patents (86)
People (45691)
Phase I (15737)
Phase II (20972)
Phase III (15398)
Pipeline (196)
Postmarket research (1560)
Preclinical (6792)
Press Release (72)
Radiopharmaceuticals (233)
Rare diseases (179)
Real estate (4582)
Regulatory (16210)
Research institute (2082)
Resumes & cover letters (198)
Southern California (888)
Startups (3217)
United States (9470)
Vaccines (443)
Weight loss (110)
Date
Today (156)
Last 7 days (676)
Last 30 days (2414)
Last 365 days (30564)
2024 (25834)
2023 (34114)
2022 (44750)
2021 (47955)
2020 (45318)
2019 (37864)
2018 (28698)
2017 (27787)
2016 (26370)
2015 (30831)
2014 (23123)
2013 (25301)
2012 (20571)
2011 (21003)
2010 (19130)
Location
Africa (600)
Arizona (116)
Asia (38473)
Australia (6242)
California (2211)
Canada (1005)
China (179)
Colorado (105)
Connecticut (107)
Europe (76236)
Florida (324)
Georgia (84)
Illinois (221)
Indiana (146)
Kansas (84)
Maryland (421)
Massachusetts (1799)
Michigan (142)
Minnesota (206)
New Jersey (688)
New York (645)
North Carolina (544)
Northern California (981)
Ohio (106)
Pennsylvania (575)
South America (846)
Southern California (888)
Texas (319)
Utah (70)
Washington State (301)
545,031 Results for "gene technologies ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
OBiO Technology will showcase at American Society of Gene & Cell Therapy
OBiO Technology Corp., Ltd. will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th.
April 28, 2024
·
3 min read
Gene therapy
Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’
in vivo
gene therapy delivery technology, which synthesizes virus capsids with better functionality and manufacturability.
October 24, 2024
·
2 min read
·
Tristan Manalac
Ori Biotech Unveils IRO Platform at Annual International Society for Cell & Gene Therapy Conference
Ori Biotech Ltd., a leader in cell and gene therapy manufacturing technology, announces the commercial launch of IRO®, a next-generation platform built specifically to overcome the current challenges in CGT manufacturing.
May 29, 2024
·
3 min read
Gene editing
Gene Editing Patent Landscape Remains ‘Clear as Mud,’ Say Patent Attorneys
The intellectual property landscape for newer gene-editing technologies, like that for CRISPR-Cas9, remains unclear and hard to navigate.
September 4, 2024
·
5 min read
·
Christoph Schwaiger
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
BioMidwest
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced that it completed exclusive commercial licensing of a gene editing technology from the University of California Berkeley.
June 5, 2024
·
2 min read
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Deals
2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million
2seventy bio, Inc., announced the completion of an asset purchase agreement by Novo Nordisk. Under the terms of the APA, Novo Nordisk has acquired the Hemophilia A program and rights to 2seventy’s in vivo gene editing technology outside of oncology and gene editing for autologous or allogeneic cell therapies of immune cells for the treatment of autoimmune disease.
June 26, 2024
·
4 min read
1 of 54,504
Next